1. Tipton, K. F. 1989. Monoamine oxidase inhibitors as antidepressants. Pages 1?24,in Tipton, K. F. and Youdim, M. B. H. (eds.) Biochemical and Pharmacological Aspects of Depression. Taylor & Francis, London.
2. Blackwell, B. 1963. Hypertensive crisis due to monoamine oxidase inhibitors. Lancet (ii): 849?951.
3. Davis, D. S., Tasuhara, H., Boobis, A. R., and George, C. F. 1984. The effects of reversible and irreversible inhibitors of monoamine oxidase on tyramine deamination in dog intestine. Pages 443?448in Tipton, K. F., Dostert, P. and Strolin Benedetti, A. (eds.) Monoamine Oxidase and Disease. Academic Press, London.
4. Dostert, P. 1984. Myth and reality of the classical MAO inhibitors, reasons for seeking a new generation. Pages 487?497in Tipton, K. F., Dostert, P. and Strolin Benedetti, A. (eds.) Monoamine Oxidase and Disease. Academic Press, London.
5. Da Prada, M., Zürcher, G., Würthrich, I., and Haefely, W. E. 1988. Ontyramine, food beverages and the reversible MAO inhibitor moclobemide. J. Neural. Transmiss. 26 (Suppl.): 33?56.